Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun;3(2):33-37.
doi: 10.18869/acadpub.cmm.3.2.33.

First case of superficial infection due to Naganishia albida (formerly Cryptococcus albidus) in Iran: A review of the literature

S Aghaei Gharehbolagh  1 , M Nasimi  2 , S Agha Kuchak Afshari  1 , Z Ghasemi  3 , S Rezaie  1
Affiliations
Case Reports

First case of superficial infection due to Naganishia albida (formerly Cryptococcus albidus) in Iran: A review of the literature

S Aghaei Gharehbolagh et al. Curr Med Mycol. 2017 Jun.

Abstract

Background and purpose: Naganishia albida (formerly Cryptococcus albidus) is a non-neoformans cryptococcal species rarely isolated as a human pathogen.

Case report: Herein, we present the case of a 26-year-old Iranian man with a superficial cutaneous lesion in the axilla. The initial treatment for pityriasis versicolor by clotrimazole was unsuccessful. We performed skin sampling based on the standard protocol and conducted further investigations by the conventional laboratory tests and molecular analysis of the skin samples. All the mentioned analyses revealed N.albida as the causative agent of infection. The minimum inhibitory concentration (MIC) analysis was carried out for the isolated agent, and the patient was treated using 100 mg daily of oral itraconazole.

Conclusion: N. albida can be the causative agent of some superficial infections. This is the first report on the successful detection and treatment of a superficial skin infection due to N. albida by oral itraconazole.

Keywords: Cryptococcus albidus; Cutaneous; Infection; Itraconazole; Naganishia albida; Superficial.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Macroscopic (A) and microscopic (B) demonstration of N. albida, which was indicated as the causative agent of superficial infection in the present case
See this image and copyright information in PMC

References

    1. Faress JA, Hejal R. Pulmonary crytpococcosis due to C albidus in a patient on Infliximab. Chest. 2004;126(4):987S–8.
    1. de Castro LE, Sarraf OA, Lally JM, Sandoval HP, Solomon KD, Vroman DT. Cryptococcus albidus keratitis after corneal transplantation. Cornea. 2005;24(7):882–3. - PubMed
    1. Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, et al. Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus. Msphere. 2017;2(4):e00238–17. - PMC - PubMed
    1. Burnik C, Altintaş N, Özkaya G, Serter T, Selcuk Z, Firat P, et al. Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia: case report and review of the literature. Med Mycol. 2007;45(5):469–73. - PubMed
    1. Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Non-neoformans cryptococcal infections: a systematic review. Infection. 2007;35(2):51–8. - PMC - PubMed

Publication types

LinkOut - more resources